体重指数对择期剖宫产腰麻期间感觉运动阻滞及升压药需求的影响
这项前瞻性观察性非劣效研究纳入两组各25名择期剖宫产产妇,比较BMI>40与BMI<32者接受10mg高比重布比卡因+10μg芬太尼腰麻后的升压药需求和阻滞高度。结果显示两组30分钟内去氧肾上腺素需求等效,肥胖组仅温度觉阻滞高度在25分钟时略高2个皮节,但阻滞消退更慢。因此单次腰麻10mg布比卡因剂量不应因病态肥胖而减少。
要点
- 肥胖组与非肥胖组腰麻后30分钟内去氧肾上腺素需求等效。
- 肥胖组25分钟温度觉阻滞高度仅高2个皮节,无临床重要意义。
- 病态肥胖产妇单次腰麻10mg布比卡因剂量不应减少。
核心结论
- 肥胖组仅在25分钟时温度觉评估的阻滞高度轻微增加,30分钟内升压药需求等效。
- 肥胖组腰麻阻滞消退时间更长,可能有利于应对更长的手术时间。
- 病态肥胖产妇单次腰麻10mg布比卡因剂量不应减少。
研究设计与样本
- 前瞻性、观察性、非劣效研究,两组各25名择期剖宫产产妇。
- O组BMI>40 kg/m²,N组BMI<32 kg/m²。
- 所有患者接受10mg高比重布比卡因+10μg芬太尼腰麻。
主要发现
- 5分钟和25分钟触觉及5分钟温度觉评估的中位阻滞高度组间无显著差异。
- 25分钟温度觉消失的中位阻滞高度O组与N组相差2个皮节(T2 vs T4,中位数差值95%CI 0-2个皮节)。
- 无阻滞平面延伸至颈段皮节。
- 前30分钟去氧肾上腺素中位剂量:N组100 μg(0-1250 μg),O组150 μg(0-900 μg),中位数差值95%CI -150 μg至100 μg。
- O组平均手术时间更长(49.1 vs 39.4 min,95%CI差值1.7-17.7 min),触觉恢复至T10平均时间更长(152 vs 132 min,95%CI差值3.8-36.2 min)。
关键数值与推荐
- 主要结局为腰麻后前30分钟去氧肾上腺素需求及最大阻滞高度(触觉和温度觉)。
- 次要结局包括去氧肾上腺素总剂量、握力变化和峰值流速。
- 无需追加镇痛药。
临床怎么用
- 病态肥胖产妇择期剖宫产单次腰麻10mg布比卡因剂量无需减少。
- 肥胖患者腰麻后升压药需求与非肥胖者相当,可按常规管理。
- 肥胖患者阻滞消退时间更长,可匹配更长的手术时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: It has been suggested that the dose requirement for spinal anesthesia (SA) is lower in obese patients for cesarean delivery (CD). In this prospective, observational, noninferiority study, we tested the hypothesis that obesity would not have a clinically important effect on vasopressor requirements or block height. METHODS: Two groups of 25 parturients, group O (body mass index [BMI] >40 kg/m) and group N (BMI <32 kg/m) requiring elective CD were recruited. All patients received 10 mg intrathecal hyperbaric bupivacaine coadministered with 10 μg fentanyl. Dermatomal levels were assessed at 5 and 25 minutes after SA, and at completion of surgery, using light touch and cold sensation in response to ethyl chloride. The primary outcomes were phenylephrine requirement in the first 30 minutes after SA, and maximum block height, measured by the sensation of touch and cold. Secondary outcomes were total phenylephrine dose required, changes in hand grip strength, and peak flow rate. RESULTS: There were no significant between-group differences in median block height as assessed by touch at 5 or 25 minutes or by temperature at 5 minutes. At 25 minutes, there was a 2-dermatome difference in median block height for loss of temperature sensation between group O and group N (T2 vs T4, 95% confidence interval [CI] of the difference in medians 0-2 dermatomes). No blocks extended to cervical dermatomes. The median (range) phenylephrine dose for the first 30 minutes was 150 µg (0-900 µg), and 100 µg (0-1250 µg) in group N and group O, respectively. The 95% CI for the difference between the 2 median doses was -150 µg to 100 µg. There were no differences in median percentage reductions in peak flow rate or median hand grip strength after SA. Mean surgical time was longer in group O than in group N (49.1 vs 39.4 min, 95% CI difference 1.7-17.7 min). The mean time for recovery of touch sensation to T10 was longer in group O (152 vs 132 min, 95% CI difference 3.8-36.2 min). No analgesic supplementation was required. CONCLUSION: Only a minor increase in block height as assessed by temperature occurred in group O at 25 minutes. Vasopressor requirements during the first 30 minutes of SA were equivalent. Time for regression of SA block level was longer in the group O, which may be beneficial considering the longer surgical time. A dose of spinal bupivacaine 10 mg for single-shot SA should not be reduced in morbidly obese parturients.
引用
- Ngaka TC, Coetzee JF, Dyer RA, et al. The Influence of Body Mass Index on Sensorimotor Block and Vasopressor Requirement During Spinal Anesthesia for Elective Cesarean Delivery. Anesth Analg. 2016. PMID: 27870737
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。